2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide has been researched along with Pain, Chronic in 1 studies
bisindolylmaleimide II: protein kinase C inhibitor; see also bisindolylmaleimide I
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ritter, DM | 1 |
Ho, C | 1 |
O'Leary, ME | 1 |
Covarrubias, M | 1 |
1 other study available for 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide and Pain, Chronic
Article | Year |
---|---|
Modulation of Kv3.4 channel N-type inactivation by protein kinase C shapes the action potential in dorsal root ganglion neurons.
Topics: Action Potentials; Animals; Calcium; Chronic Pain; Female; Ganglia, Spinal; Indoles; Maleimides; Mem | 2012 |